ANI Pharmaceuticals | ANIP - Fremdkapital





Fremdkapital Veränderung Datum
AbbVie USD 64.53B 5.59B 2026-03
ANI Pharmaceuticals USD 280.15M 5.84M 2026-06
Aurora Cannabis CAD 18.13M 15.07M 2026-03
Canopy Growth CAD 217.12M 7.87M 2026-03
Eli Lilly USD 47.86B 8.49B 2026-06
Emergent BioSolutions USD 446.5M 1.7M 2023-12
Heron Therapeutics USD 140.64M 975K 2025-12
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Nektar Therapeutics USD 60.27M 2.89M 2026-03
Novartis USD 37.45B 7.86B 2026-03
Omeros USD 403.72M 27.2M 2024-06
Perrigo USD 3.28B 337.7M 2026-06
Sun Pharmaceuticals INR 3.93B 309.9M 2026-03
Teva Pharmaceutical Industries USD 12.09B 1.92B 2026-06